Form 4: Courtney Mather Reports Chemours Co Stock Transactions

Courtney Mather, a Director at The Chemours Company, reported transactions involving deferred stock units on June 30, 2026.

Summary

• Courtney Mather, a Director at The Chemours Company (CC), reported a transaction on June 30, 2026.
• The transaction involved the acquisition of 1,401 deferred stock units.
• These deferred stock units are economically equivalent to one share of the company's common stock.
• The deferred stock units will become payable in the month following the Reporting Person's termination of service as a director.
• The reported value associated with these units is $20.52 per unit, totaling $8,983.8481.
• This acquisition increases the total number of deferred stock units and dividend equivalent units beneficially owned to 8,983.8481.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation-related transaction for a director rather than a new strategic development or significant financial event.

Positives

• Acquisition of 1,401 deferred stock units by a Director, indicating continued alignment with company performance.
• The deferred stock units are valued at $20.52 per unit, suggesting a current market valuation for the stock.

Future Outlook

The deferred stock units become payable in the month following the Reporting Person's termination of service as a director.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and reflect compensation structures common in the chemicals industry, where long-term incentives are often tied to stock performance.

Stakeholder Impact

• Shareholders: The transaction is a standard compensation event and does not immediately impact share count or market dynamics, but reflects ongoing executive compensation practices.

Next Steps

• Deferred stock units will be paid out in the month following the Reporting Person's termination of service as a director.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Deferred Stock Units, The Chemours Company, Courtney Mather, Beneficial Ownership, Director Compensation